China SXT Pharmaceuticals, Inc. (SXTC) Form 6-K — Oct 8, 2026
China SXT Pharmaceuticals (NASDAQ: SXTC) announced a $12 million registered direct offering of 8,000,000 Class A ordinary shares (or pre-funded warrants) priced at $1.50 per share, with closing expected on or about October 9, 2026. Investors also receive 8 million common warrants exercisable at $2.75 per share with a 1-year term; each warrant includes a zero-cash-exercise option allowing the holder to acquire up to 9 Class A shares, implying significant potential dilution. The company also granted investors an additional purchase right for up to $12 million of securities on the same terms within 30 days after closing, doubling potential proceeds and dilution.
Key figures
- Gross Proceeds
- 12000000
- Offering Price
- 1.5
- Shares Offered
- 8000000
- Warrant term
- 1-year, immediately exercisable
- Expected close
- on or about October 9, 2026
- Warrant exercise price
- 2.75
- Additional purchase right
- up to $12 million on same terms within 30 days after closing
- Warrant zero cash feature
- each warrant permits acquiring up to 9 Class A shares
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.